Alternative Routes of Administration for Therapeutic Antibodies -State of the Art - Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100 Accéder directement au contenu
Article Dans Une Revue Antibodies Année : 2022

Alternative Routes of Administration for Therapeutic Antibodies -State of the Art

Résumé

Background: For the past two decades, there has been a huge expansion in the development of therapeutic antibodies, with 6 to 10 novel entities approved each year. Around 70% of these Abs are delivered through IV injection, a mode of administration allowing rapid and systemic delivery of the drug. However, according to the evidence presented in the literature, beyond the reduction of invasiveness, a better efficac can be achieved with local delivery. Consequently, efforts have been made toward the development of innovative methods of administration, and in the formulation and engineering of novel Abs to improve their therapeutic index. Objective: This review presents an overview of the routes of administration used to deliver Abs, different from the IV route, whether approved or in the clinical evaluation stage. We provide a description of the physical and biological fundamentals for each route of administration, highlighting their relevance with examples of clinically-relevant Abs, and discussing their strengths and limitations. Methods: We reviewed and analyzed the current literature, published as of the 1 April 2022 using MEDLINE and EMBASE databases, as well as the FDA and EMA websites. Ongoing trials were identified using clinicaltrials.gov. Publications and data were identified using a list of general keywords. Conclusions: Apart from the most commonly used IV route, topical delivery of Abs has shown clinical successes, improving drug bioavailability and efficacy while reducing side-effects. However, additional research is necessary to understand the consequences of biological barriers associated with local delivery for Ab partitioning, in order to optimize delivery methods and devices, and to adapt Ab formulation to local delivery. Novel modes of administration for Abs might in fine allow a better support to patients, especially in the context of chronic diseases, as well as a reduction of the treatment cost.
Fichier principal
Vignette du fichier
Review Administration route for antibodies_HAL-1830909.pdf (914.88 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03769100 , version 1 (05-09-2022)

Identifiants

Citer

Aubin Pitiot, Nathalie Heuzé-Vourc’h, Thomas Sécher. Alternative Routes of Administration for Therapeutic Antibodies -State of the Art. Antibodies, 2022, 11 (3), pp.56. ⟨10.3390/antib11030056⟩. ⟨hal-03769100⟩
18 Consultations
62 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More